Skip to main content
BKHARNasdaqinactive

Black Hawk Acquisition Corp

·Danville, CA, United States·CEO: Mr. Kent Louis Kaufman

BKHAR evidence brief

What we can confirm

No verified snapshot fields are available yet.

What it means

The company data is ready for cross-source review; unsupported conclusions remain unknown.

What to watch

Watch the next source-backed data update.
BioSniper AIPage evidence connected

Prepared research question

What matters most for BKHAR—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

Market Cap

$1.8M

Cash Runway

Lead Asset

Next Catalyst

Run Black Hawk Acquisition Corp through your own thesis

Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.

Your protocol can:

  • Turn available Black Hawk Acquisition Corp facts into screen rules or deeper checks
  • Show cited findings, blockers, and unresolved evidence together
  • Save the logic and rerun it as the company evidence changes
Run a thesis on this company — freeRun a thesis on this company

Financials

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

15

Total value held

$893K

Showing top 10 of 15 institutional holders of Black Hawk Acquisition Corp. Open the full 13F history after sign-in.

Short Interest

% of float
-
Days to cover
Shares short
-
Daily short volume (Jun 12, 2026)
29.2%

Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →

BKHAR short interest

Governance

Frequently asked questions

Who is the CEO of Black Hawk Acquisition Corp?

Mr. Kent Louis Kaufman is the chief executive officer of Black Hawk Acquisition Corp (BKHAR).

Where is Black Hawk Acquisition Corp headquartered?

Black Hawk Acquisition Corp (BKHAR) is headquartered in Danville, CA, United States.

925 companies232,681 SEC filings21,419 clinical trials100% citation-verification pass rate (7d)How we verify →

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.